Category: PTX3

Immunological dysfunction persists for 8 months following initial mild-to-moderate SARS-CoV-2 infection

Posted on | Posted on John Murphy | Leave a Comment on Immunological dysfunction persists for 8 months following initial mild-to-moderate SARS-CoV-2 infection

Authors: Chansavath Phetsouphanh, David R. Darley, Daniel B. Wilson, Annett Howe, C. Mee Ling Munier, Sheila K. Patel, Jennifer A. Juno, Louise M. Burrell, Stephen J. Kent, Gregory J. Dore, Anthony D. Kelleher & Gail V. Matthews  Nature Immunology volume 23, pages210–216 (2022) June 30, 2022 Nature Immunology volume 23, pages210–216 (2022) Abstract A proportion of patients surviving acute coronavirus disease 2019 (COVID-19) infection develop post-acute COVID syndrome (long COVID (LC)) lasting longer […]

New Clues To Long Covid: Prolonged Inflammatory Response

Posted on | Posted on John Murphy | Leave a Comment on New Clues To Long Covid: Prolonged Inflammatory Response

Authors: William A. Haseltine January 2922 Posted July 2022 Forbes For many Covid-19 patients, the end of the acute stage of infection is only the beginning of another difficult experience: Long Covid. Defined by the persistence of physical and neuropsychiatric symptoms over a period of 12 weeks or longer, the exact causes of long Covid […]